mRNA vaccines — a new era in vaccinology

By N. Pardi, Michael J. Hogan, F. Porter, D. Weissman. Nature reviews. Drug discovery, 2018

3,917 citations recorded by the source corpus.

mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration. However, their application has until recently been restricted by the instability and inefficient in vivo delivery of mRNA. Recent technological advances have now largely overcome these issues, and multiple mRNA vaccine platforms against infectious diseases and several types of cancer have demonstrated encouraging results in both animal models and humans. This Review provides a detailed overview of mRNA vaccines and considers future directions and challenges in advancing this promising vaccine platform to widespread therapeutic use.

Subfields: Animal Science and Zoology, Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/5e2f349c96793e6575615cf81b08b55f8694b50e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. E. Wherry
  2. Michael J. Hogan
  3. N. Pardi
  4. Rafi Ahmed
  5. A. Schietinger
  6. P. Greenberg
  7. J. Snyder-Cappione
  8. Anna C. Belkina

In Molecular Biology

  1. Michael J. Hogan
  2. Min Wu
  3. N. Pardi

Citations in the corpus